Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Autoantibodies Against Vimentin and Α-Enolase in Rheumatoid Arthritis Patients Publisher



Ebrahimirad M1 ; Khatami S1 ; Akhbari H2 ; Mahmoudzadehniknam H3, 5 ; Valadbeigi S1 ; Mahmoudi M4 ; Jamshidi A4 ; Riazirad F3, 5 ; Saghiri R1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran
  2. 2. Department of Rheumatology, Birjand University of Medical Sciences, Iran
  3. 3. Department of Immunology, Pasteur Institute of Iran, Tehran, Iran
  4. 4. Rheumatology Research Center, Tehran University of Medical Sciences, Iran
  5. 5. Department of Immunology, Pasteur Institute of Iran, Tehran, Iran

Source: Reumatologia Published:2021


Abstract

Introduction: Rheumatoid arthritis (RA) is categorized as an autoimmune disease with a frequency of 0.2–1% worldwide. It is reported that various autoantibodies are produced in the RA population, particularly against citrullinated peptides. Among various candidate markers for RA diagnosis, the citrullinated proteins have the highest specificity and sensitivity for both diagnosis and prognosis of RA. Anti-mutated citrullinated vimentin and α-enolase constitute a new class of autoantibodies for early detection of RA. Material and methods: 45 serum samples and 19 synovial fluid (SF) specimens collected from RA patients were considered for American College of Rheumatology criteria and 20 serum samples and 10 SF specimens were provided from healthy subjects as a control group. To assess the quantity of anti-citrullinated protein antibodies (ACPA), anti-mutated citrullinated vimentin (MCV) and antiα-enolase in the serum and SF of RA patients were determined by the enzyme-linked immunosorbent assay (ELISA) method. For the evaluation of disease activity and joint destruction, we used the Disease Activity Score of 28 joints based on erythrocyte sedimentation rate (ESR) Disease Activity Score 28 (DAS28). Furthermore, to measure the molecular weight of vimentin and α-enolase, electrophoresis on 10% SDS-PAGE was performed as described before. Results: The anti-α-enolase level among serum samples from RA patients was significantly higher than in healthy subjects (4.49 ±0.20 ng/ml vs. 0.76 ±0.12 ng/ml) (p < 0.001). There was a direct relation between α-enolase quantity and (rheumatoid factor) RF and C-reactive protein (CRP) levels. The mean ESR value in positive and negative ACPA patients was 38.2 ±22.6 mm/h and 9.2 ±5.8 mm/h respectively (p < 0.0001). The mean DAS28-ESR was 3.3. The level of anti-MCV in the serum of RA patients (244.6 ±53.3 U/ml) was higher than in serum of the healthy group (148.73 ±71.8) (p < 0.0001). The level of anti-MCV in the SF of patients was 687.5 ±148.4 U/ml. Conclusions: In conclusion, both autoantibodies against MCV and α-enolase are two important markers that increase in serum and SF of RA patients and are specific for diagnosis of RA disease. © 2020 Termedia Publishing House Ltd.. All rights reserved.
Related Docs
1. Autoimmune Diseases, Clinical Immunology (2022)
Experts (# of related papers)